Many Bright Ideas Technologies Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MBGNF research report →
Companywww.medbiogene.com
Many Bright Ideas Technologies Inc. does not have significant operations. Previously, the company was engaged in the life science business with a focus on the development and commercialization of genomic-based tests for non-small-cell lung cancer.
- CEO
- Iain Weir-Jones
- IPO
- 2018
- Employees
- 7
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $101.82K
- P/E
- -2.02
- P/S
- 0.00
- P/B
- -0.48
- EV/EBITDA
- -2.99
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 26.34%
- ROIC
- 22.22%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-51,515 · 11.35%
- EPS
- $-0.00 · 11.76%
- Op Income
- $-51,515
- FCF YoY
- -521.16%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 1.49
- Avg Volume
- 540
Get TickerSpark's AI analysis on MBGNF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MBGNF Coverage
We haven't published any research on MBGNF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MBGNF Report →